ArticleThoracic cancer2024

Quantitative evaluation of the impact of relaxing eligibility criteria on the risk-benefit profile of drugs for lung cancer based on real-world data.

Huiyao Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.